MAP3K7 and colonic neoplasm: The careful comparison of KRAS-dependent and KRAS-independent colon cancers led to the identification of MAP3K7, encoding the TGF-β-activated kinase (TAK1), as a driver of cell survival of KRAS-mutated-dependent, APC-deficient cells [130].